CoverageForm 410-K10-Q8-K13D13G13F

Hamill Laura

CIK 0001751804
Director

Filings

12

Latest Sep 19, 2025

Issuers covered

5

Showing

12 of 12

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Hamill Laura. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Hamill Laura has filed

TickerIssuerFilingsLast filed
YMABY-Mabs Therapeutics, Inc.4Sep 19, 2025
PRDSPardes Biosciences, Inc.3Aug 31, 2023
ANABAnaptysbio, Inc2Jan 10, 2023
JAZZJazz Pharmaceuticals PLC2Aug 11, 2025
SCLXScilex Holding Co1Jan 17, 2023

All filings

12 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue